Market Overview

Morning Market Movers

Share:
Related CYTR
CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer)
This Is A Near-Term Driver At CytRX
Related BGMD
Earnings Scheduled For March 31, 2015
Earnings Scheduled For August 14, 2014

CytRx (NASDAQ: CYTR) rose 68.20% to $4.02 on positive Phase 2B data.

BG Medicine (NASDAQ: BGMD) moved up 41.67% to $1.53 after the company confirmed final determination by CMS of 2014 reimbursement for BGM galectin-3 test.

LiveDeal (NASDAQ: LIVE) shares jumped 21.34% to $3.98 after the company announced the launch of livedeal.com in Los Angeles.

NanoString Technologies (NASDAQ: NSTG) jumped 17.30% to $16.48 as the company announced adoption of the Prosigna Breast Cancer Assay by leading US clinical laboratories and cancer centers.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (CYTR + BGMD)

Around the Web, We're Loving...